Eronib-150 (Erlotinib) 150mg

Introduction to Tarceva (Erlotinib) 150mg 

Tarceva (Erlotinib) 150mg is a targeted anticancer medicine used in the treatment of certain types of lung cancer and pancreatic cancer. It works by blocking specific signals that cancer cells need to grow and divide.

Tarceva 150mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Tyrosine Kinase Inhibitors (TKIs). It contains Erlotinib, which helps slow or stop the growth of cancer cells.

In some markets, Eronib-150 150mg is available as a local brand containing the same active ingredient Erlotinib, offering similar therapeutic effects when prescribed by a qualified healthcare professional.

What Is Tarceva (Erlotinib)? 

Tarceva is the brand name for Erlotinib, an oral medication widely used in targeted cancer treatment.

Erlotinib belongs to a class of medicines known as Epidermal Growth Factor Receptor (EGFR) inhibitors, a type of tyrosine kinase inhibitor. These medicines block signals that promote cancer cell growth.

Generic versions such as Eronib-150 150mg contain the same active compound and may be used depending on physician recommendation and availability.

Drug Class and Mechanism of Action 

Erlotinib is classified as an EGFR tyrosine kinase inhibitor with antineoplastic properties.

How Erlotinib Works 

It works in several ways:

• Blocks EGFR signaling pathways
• Inhibits cancer cell proliferation
• Promotes cancer cell death

How Tarceva Works in the Body 

Certain cancers rely on EGFR signals to grow and spread.

Key Actions of Erlotinib 

• Slowing tumor growth
• Reducing cancer cell division
• Enhancing targeted cancer therapy outcomes

Generic versions such as Eronib-150 provide the same targeted anticancer effects when used appropriately.

Medical Uses of Tarceva 150mg 

For Non-Small Cell Lung Cancer 

Erlotinib is commonly used in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC).

Potential Benefits 

• Improved progression-free survival
• Targeted action on cancer cells
• Better tolerability compared to some chemotherapy

For Pancreatic Cancer 

It may be used in combination with other therapies for pancreatic cancer.

Treatment Benefits 

• Slowed disease progression
• Enhanced treatment response
• Improved disease control

Who Can Take Eronib-150 150mg? 

Eligibility Criteria 

Patients may be prescribed this medicine if they:

• Have NSCLC or pancreatic cancer
• Show EGFR mutation (for lung cancer)
• Are evaluated by an oncologist

Who Should Avoid Tarceva 150mg 

This medicine should NOT be used by:

• Patients with severe liver disease
• Individuals with hypersensitivity to Erlotinib
• Pregnant or breastfeeding women unless advised

Tarceva 150mg Dosage and Administration 

Standard Dosage Guidelines 

• Typical dose: 150mg once daily
• Taken on an empty stomach (1 hour before or 2 hours after food)
• Swallow tablet whole with water

Dosage Adjustments 

Doctors may adjust dosage depending on:

• Liver function
• Side effects
• Treatment response

Side Effects of Tarceva 150mg 

Common Side Effects 

• Skin rash
• Diarrhea
• Loss of appetite
• Fatigue

Serious Side Effects 

• Severe lung problems (interstitial lung disease)
• Liver toxicity
• Severe skin reactions
• Eye disorders

Storage 

Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

Frequently Asked Questions (FAQs) 

1. Is Erlotinib chemotherapy? 

No, it is a targeted therapy, not traditional chemotherapy.

2. Should it be taken with food? 

No, it should be taken on an empty stomach for better absorption.

3. Can it cause skin rash? 

Yes, skin rash is a common side effect.

4. Is it used long-term? 

Yes, depending on treatment response and tolerance.

5. Is Eronib-150 150mg the same as Tarceva? 

Yes, both contain Erlotinib with similar therapeutic effects.

6. Do I need a prescription? 

Yes, it is a prescription-only anticancer medicine.

Medical Disclaimer 

Disclaimer:
This content is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting cancer treatment.